Tag: Moderna

Published by: Global News
Published on: October 4, 2024
By Saba Aziz

Updated COVID-19 vaccines are starting to roll out to some high-risk Canadians, but others will have to wait a little while longer before these new shots are offered to them.

Last month, Health Canada approved Pfizer and Moderna’s latest COVID-19 vaccines targeting the most recent variants of the virus.

Both shots are approved for everyone aged six months and older.

The new mRNA vaccines from both pharmaceutical companies target the KP.2 subvariant of Omicron that was dominating COVID-19 spread earlier this year.

Comments closed

vaccines

For Canadians seeking a non-mRNA COVID vaccine, lack of Novavax shot is ‘unfair,’ advocates say

Published October 3, 2024

Published by: CTV News / The Canadian Press
Published on: October 3, 2024
By Hannah Alberga, Nicole Ireland

The federal government’s decision to not provide Novavax’s COVID-19 vaccine this respiratory virus season raises health equity concerns, experts and advocates say, as some Canadians look to the U.S. to get the shot.

The Public Health Agency of Canada said it won’t provide the protein-based vaccine called Nuvaxovid because the manufacturer required a minimum order that far exceeds last year’s uptake of the vaccine.

The health agency said 125,000 Nuvaxovid doses were ordered in 2023, but only 5,529 were administered. This fall, it will only supply provinces and territories with the reformulated Pfizer-BioNTech and Moderna mRNA COVID-19 vaccines.

But some Canadians who say they are immunocompromised and have had adverse reactions to the mRNA vaccines are calling the decision unfair.

Comments closed

vaccines

Canadian government not ordering Novavax’s protein-based COVID-19 vaccine this year

Published October 1, 2024

Published by: The Canadian Press
Published on: October 1, 2024
By Nicole Ireland

TORONTO – The Public Health Agency of Canada says it is not providing Novavax’s COVID-19 vaccine this respiratory virus season, citing low demand.

It says the manufacturer requires a minimum order of its updated protein-based vaccine, called Nuvaxovid, which far exceeds the uptake by Canadians last year.

The agency says a very small portion of the doses ordered in 2023 were used and that its decision reflects efforts to limit vaccine wastage.

It is distributing two mRNA vaccines — made by Pfizer-BioNTech and Moderna — that are approved for adults and children six months and older.

Comments closed

vaccines

Health Canada approves Pfizer-BioNTech’s updated COVID-19 vaccine

Published September 24, 2024

Published by: The Canadian Press
Published on: September 24, 2024
By Nicole Ireland, Hannah Alberga

Health Canada approved Pfizer-BioNTech’s updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine formulations that protect against the most recently circulating variants of the virus.

Pfizer-BioNTech’s mRNA vaccine, called Comirnaty, targets the KP.2 subvariant of Omicron, replacing the previous version that targeted the XBB.1.5 Omicron subvariant.

The approval of Comirnaty follows last week’s authorization of Moderna’s updated Spikevax mRNA vaccine and Novavax’s updated protein-based vaccine, Nuvaxovid.

Comments closed

Alberta

Moderna’s updated COVID-19 vaccine is coming to Alberta, but Novavax shots are not

Published September 23, 2024

Published by: CBC News
Published on: September 23, 2024
By Jennifer Lee

With the approval of Moderna’s updated COVID-19 vaccine, doctors are hoping the shots will be available soon and Albertans will opt to roll up their sleeves to get one.

Last week, Health Canada announced it had authorized Moderna’s new formulation, which targets the recent KP.2 subvariant, and that shipments would arrive within days.

A decision on Pfizer’s new formulation is expected in the next few weeks.

Comments closed

vaccines

No good option: These Canadians want to be protected against COVID but are unhappy with the choice of vaccines this fall

Published September 13, 2024

Published by: Investigative Journalism Foundation
Published on: September 13, 2024
By Tori Marlan

The federal government has decided against procuring a protein-based COVID-19 vaccine for the fall immunization campaign — despite it being the only type that some immunocompromised people say they have been able to tolerate.

While the mRNA vaccines made by Pfizer and Moderna are effective at preventing severe illness, hospitalization and death, some people with autoimmune diseases say the jabs can come with a terrible trade-off.

Comments closed

vaccines

No Novavax COVID-19 vaccine in Canada this fall, immunocompromised N.B. woman feels ‘expendable’

Published September 6, 2024

Published by: CBC News
Published on: September 6, 2024
By Bobbi-Jean MacKinnon

Linda Wilhelm, 64, of Bloomfield, N.B., is planning a road trip to the United States. But it’s not to go sightseeing or shopping.

Wilhelm, who suffers from severe rheumatoid arthritis, hopes to get the updated Novavax COVID-19 vaccine, which won’t be available in Canada as part of the fall vaccination campaign, unless provinces and territories order doses on their own.

Wilhelm, president of the Canadian Arthritis Patient Alliance and a member of the Canadian Immunocompromised Advocacy Network, says the protein-based vaccine is a better option for immunocompromised people like her than the more common Pfizer-BioNTech and Moderna mRNA vaccines. She says she feels “expendable” and urges the federal government to reconsider.

Less than two months ago, the network wrote to numerous federal, provincial and territorial officials, calling for improved access to Novavax and increased awareness.

Comments closed

Novavax now! We need access to the Novavax COVID-19 vaccine!

Photo of two vials of a vaccine and a syringe, accompanied by white and gold text on a blue background reading: Novavax now! We need access to the Novavax COVID-19 vaccine. StillCoviding.ca #NovavaxNow Photo: oasisamuel / Adobe.

take action

Novavax now! We need access to the Novavax COVID-19 vaccine!

Published August 25, 2024

📣 Let PHAC and health ministers know you want timely access to the Novavax COVID-19 vaccine this fall

✉️ Send letters to PHAC and health ministers to voice your support for access to the Novavax COVID-19 vaccine this fall. Use our online tool to send emails.

Comments closed

vaccines

FDA may greenlight updated Covid-19 vaccines as soon as next week, sources say

Published August 16, 2024

Published by: CNN
Published on: August 16, 2024
By Meg Tirrell

The US Food and Drug Administration is poised to sign off as soon as next week on updated Covid-19 vaccines targeting more recently circulating strains of the virus, according to two sources familiar with the matter, as the country experiences its largest summer wave in two years.

The agency is expected to greenlight updated mRNA vaccines from Moderna and Pfizer/BioNTech that target a strain of the virus called KP.2, said the sources, who declined to be named because the timing information isn’t public. It was unclear whether the agency simultaneously would authorize Novavax’s updated shot, which targets the JN.1 strain.

The move would be several weeks ahead of last year’s version of the vaccine, which got FDA signoff on September 11.

Comments closed

vaccines

Older, immunocompromised people may get COVID-19 vaccine dose in spring, NACI says

Published January 12, 2024

Published by: CTV News / The Canadian Press
Published on: January 12, 2024

Canada’s National Advisory Committee on Immunization says some groups of people vulnerable to severe illness from COVID-19 should be eligible for another dose of vaccine in the spring.

The recommendation issued Friday says people aged 65 and older, residents of long-term care homes and seniors living in other congregate settings may get another shot of the vaccine targeted to the XBB.1.5 variant.

It also says children and adults aged six months and older who are moderately to severely immunocompromised due to an underlying condition may also get the booster.

Comments closed

vaccines

Canada has ‘sufficient supply’ of new COVID-19 vaccines amid ‘pandemic amnesia,’ experts say

Published November 9, 2023

Published by: CTV News
Published on: November 9, 2023
By Mitchell Consky

As doctors recommend new COVID-19 vaccine doses to combat the XBB.1.5 Omicron subvariant, a mutation of COVID-19 that has continued to spread despite misconceptions that the virus is in the past, officials say Canada has sufficient supply.

Comments closed

vaccines

Is the Novavax COVID Vaccine Better than mRNA Vaccines? What We Know So Far

Published October 16, 2023

Published by: Scientific American
Published on: October 16, 2023
By Sara Reardon

As the updated COVID vaccines roll out around the country, one more competitor has joined the mix. In early October the U.S. Food and Drug Administration authorized a new booster shot made by the company Novavax. Like the mRNA-based Pfizer and Moderna shots, it targets a SARS-CoV-2 variant, XBB.1.5, which is a descendant of Omicron.

Comments closed

Nova Scotia

Appointments for new Moderna COVID-19 vaccine now available in N.S.

Published October 6, 2023

Published by: CTV News
Published on: October 6, 2023
By Jesse Huot

Appointments are now available in Nova Scotia for a new monovalent Moderna COVID-19 vaccine, which the provincial government says provides the best protection against the latest strain of the virus.

Comments closed

vaccines

With flu season on the horizon, we answer your COVID-19 questions

Published September 13, 2023

Published by: CBC News
Published on: September 13, 2023

After 3½ years of COVID-19, many Canadians have learned how to make decisions around living with the virus. But as Canada heads into another cold…

Comments closed

vaccines

US CDC recommends broad use of updated COVID‑19 vaccines

Published September 13, 2023

Published by: Reuters
Published on: September 13, 2023
By Bhanvi Satija and Michael Erman

The U.S. Centers for Disease Control and Prevention director on Tuesday signed off on broad use of updated COVID-19 vaccines approved by the government – covering ages 6 months and up – as the country prepares to start a vaccination campaign within days.

Comments closed

vaccines

Health Canada approves Moderna’s updated COVID-19 vaccine

Published September 12, 2023

Published by: CBC News
Published on: September 12, 2023
By Lauren Pelley

Health Canada has approved Moderna’s updated COVID-19 vaccine for all Canadians who are six months of age and older — while two other options for fall shots remain in the regulatory pipeline.

Comments closed

vaccines

Moderna’s updated COVID vaccine targeting XBB.1.5 approved in Canada

Published September 12, 2023

Published by: Global News
Published on: September 12, 2023
By Katie Dangerfield

Health Canada has given the green light to an eagerly anticipated fall COVID-19 booster shot in hopes of bolstering the nation’s defence against the virus as the fall season approaches.

Comments closed

vaccines

Santé Canada approuve la mise à jour du vaccin de Moderna contre la COVID-19

Published September 12, 2023

Published by: Le Devoir / The Canadian Press
Published on: September 12, 2023
By Michel Saba

Health Canada announced on Tuesday that it is authorizing the use of an updated Moderna COVID-19 vaccine for all Canadians over the age of six months, at a time when federal public health has recommended that Canadians roll up their sleeves and return for vaccination.

Comments closed

Tag: Moderna

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

📣 Let PHAC and health ministers know you want timely access to the Novavax COVID-19 vaccine this fall

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts